Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $0.41 | $0.41 | $0.41 |
| Q2 2026 | 1 | $0.44 | $0.44 | $0.44 |
| Q3 2026 | 1 | $0.43 | $0.43 | $0.43 |
| Q4 2026 | 1 | $0.43 | $0.43 | $0.43 |
| Q1 2027 | 1 | $0.65 | $0.65 | $0.65 |
| Q2 2027 | 1 | $0.64 | $0.64 | $0.64 |
| Q3 2027 | 1 | $0.65 | $0.65 | $0.65 |
| Q4 2027 | 1 | $0.74 | $0.74 | $0.74 |
| Q1 2028 | 1 | $0.75 | $0.75 | $0.75 |
Usana Health Sciences Inc last posted its earnings results on Tuesday, May 5th, 2026. The company reported $0.61 earnings per share for the quarter, topping analysts' consensus estimates of $0.44 by $0.17. The company had revenue of 250.22 M for the quarter and had revenue of 925.26 M for the year. Usana Health Sciences Inc has generated $1 earnings per share over the last year ($0.58 diluted earnings per share) and currently has a price-to-earnings ratio of 39.96. Usana Health Sciences Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | N/A | $0.41 | N/A | $240.99 M | $250.22 M |
| 03/16/2026 | Q4 2025 | N/A | -$0.10 | N/A | N/A | $226.20 M |
| 11/05/2025 | Q3 2025 | N/A | -$0.36 | N/A | N/A | $213.67 M |
| 08/05/2025 | Q2 2025 | N/A | $0.52 | N/A | N/A | $235.85 M |
| 05/06/2025 | Q1 2025 | N/A | $0.49 | N/A | N/A | $249.54 M |
| 03/12/2025 | Q4 2024 | N/A | $0.23 | N/A | N/A | $213.61 M |
| 11/05/2024 | Q3 2024 | N/A | $0.56 | N/A | N/A | $200.22 M |
| 08/06/2024 | Q2 2024 | N/A | $0.55 | N/A | N/A | $212.87 M |
| 05/07/2024 | Q1 2024 | N/A | $0.86 | N/A | N/A | $227.80 M |
| 02/27/2024 | Q4 2023 | N/A | $0.88 | N/A | N/A | $221.08 M |
| 11/07/2023 | Q3 2023 | N/A | $0.59 | N/A | N/A | $213.37 M |
| 08/08/2023 | Q2 2023 | N/A | $0.90 | N/A | N/A | $238.20 M |
| 05/09/2023 | Q1 2023 | N/A | $0.95 | N/A | N/A | $248.36 M |
| 02/28/2023 | Q4 2022 | N/A | $0.67 | N/A | N/A | $227.96 M |
| 11/08/2022 | Q3 2022 | N/A | $0.78 | N/A | N/A | $233.30 M |
| 08/09/2022 | Q2 2022 | N/A | $1.00 | N/A | N/A | $264.47 M |
| 05/11/2022 | Q1 2022 | N/A | $1.16 | N/A | N/A | $272.87 M |
| 03/01/2022 | Q4 2021 | N/A | $1.04 | N/A | N/A | $267.30 M |
| 11/10/2021 | Q3 2021 | N/A | $1.37 | N/A | N/A | $274.35 M |
| 08/11/2021 | Q2 2021 | N/A | $1.89 | N/A | N/A | $336.84 M |
In the previous quarter, Usana Health Sciences Inc (:USNA) reported $0.61 earnings per share (EPS) to beat the analysts' consensus estimate of $0.44 by $0.17.
The conference call for Usana Health Sciences Inc's latest earnings report can be listened to online.
The conference call transcript for Usana Health Sciences Inc's latest earnings report can be read online.
Usana Health Sciences Inc (:USNA) has a recorded annual revenue of $925.26 M.
Usana Health Sciences Inc (:USNA) has a recorded net income of $10.76 M.Usana Health Sciences Inc has generated $0.58 earnings per share over the last four quarters.
Usana Health Sciences Inc (:USNA) has a price-to-earnings ratio of 39.96 and price/earnings-to-growth ratio is -0.54.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED